A segment of Staphylococcus aureus clumping factor A with fibrinogen-binding activity (ClfA221–550) inhibits platelet-plug formation in mice
Abstract
We previously reported that the fibrinogen-binding segment (residues 221–550) of Staphylococcus aureus clumping factor A (ClfA), which binds to fibrinogen γ chain C-terminus, exerted inhibitory effects on platelet aggregation and fibrin clot formation in vitro. Here, we further demonstrated the effectiveness of using ClfA221–550 to inhibit platelet-rich thrombus formation in vivo. Platelet-rich thrombi were formed in the mesenteric venules of fluorescein-loaded mice by filtered light illumination. It grew rapidly and ultimately resulted in the cessation of blood flow due to vessel occlusion. Given by intravenous bolus injection, ClfA221–550 delayed occlusive thrombi formation in a dose-dependent manner: 2-, 3- and 4.5-fold prolongations of vessel occlusion time were attained with 0.69, 6.9 and 34.5 mg/kg of ClfA221–550, respectively. Reduced fibrin clot formation at the late phase with plasmas, which were prepared from ClfA221–550-treated mice, was also dose-dependent. The suppression of fibrin formation ex vivo coincided with the delay of occlusive thrombus formation in vivo, suggesting that the antithrombotic effect of ClfA221–550 may result from the blockade of fibrinogen γ chain C-terminal functions, in mediating platelet aggregation and fibrin clot formation. Administration of ClfA221–550 also lengthened the tail bleeding of mice; however, significant effect was achieved only with a higher dosage, namely 34.5 mg/kg. These results together showed that blockade of fibrinogen γ chain C-terminus with ClfA221–550 preferentially affected platelet-rich thrombus formation rather than normal haemostasis, thus providing a rationale for selecting fibrinogen γ chain C-terminus as a new target for thrombotic intervention.
Abbreviations: ClfA, clumping factor A, GP, glycoprotein, GST, glutathione S-transferase, TBS, Tris-buffered saline, SDS-PAGE, sodium dodecylsulfate-polyacrylamide gel electrophoresis, aPTT, activated partial thromboplastin time, PT, prothrombin time
Keywords: Antithrombotic, Fibrinogen γ chain C-terminus, Platelet, Clumping factor A, Fibrinogen binding protein
To access this article, please choose from the options below
PII: S0049-3848(07)00119-3
doi:10.1016/j.thromres.2007.03.019
© 2007 Elsevier Ltd. All rights reserved.
